Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07105397 · ClinicalTrials.gov registry record · NA
Evaluating Conversational Artificial Intelligence for Depression Management
A NA study, sponsored by George Mason University.
- Not yet
- Registry status
- NA
- Development phase
- 130
- Enrollment target
NCT07105397: Clinical Trial NA study, sponsored by George Mason University.
NCT07105397 is a NA study that has not yet begun recruiting, run by George Mason University. The registered enrollment target is 130 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07105397, a NA study, has not yet begun recruiting, sponsored by George Mason University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate how a conversational method of collecting medical history affects patients' perceptions and experiences compared to clinical care as usual. This conversational AI intake system collects medical history information, can be completed by participants at home, and do not disrupt routine clinical care. The primary questions this study aims to answer are: 1\) Does conversational intake affect patients' perceptions of empathy during their clinical interactions? This will be a prospective study that follows a cohort of participants for four (4) months after engaging with the AI intake system. Because each participant serves as his/her own control, both comparators will be administered within-subject, and the order of exposure (AI intake vs. usual care) will be randomized to minimize sequence effects. After completing the AI intake method, participants will rate their experience, particularly in terms of empathy and compare it to their usual interactions with their own clinicians.
Primary Outcome
The primary outcome assesses the impact of intake methods (conversational AI vs. structured survey) on patients' perceptions of empathy. Patient empathy perceptions will be measured using the Jefferson Scale of Empathy (JSE), a validated instrument. A higher JSE score means higher perceptions of empathy. We hypothesize that patients interacting with the conversational AI will report higher perceived empathy scores compared to those using the structured survey. For evaluation of impact of compara
Interventions
- OTHER Conversational AI system vs Usual Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2026-04-15 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
What is known before NCT07105397 opens enrollment
NCT07105397 is an interventional study that assigns participants to a tested intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 1 intervention - of which Conversational AI system vs Usual Care is the first listed.
NCT07105397 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07105397 about?
NCT07105397 is a clinical study titled "Evaluating Conversational Artificial Intelligence for Depression Management". The goal of this clinical trial is to evaluate how a conversational method of collecting medical history affects patients' perceptions and experiences compared to clinical care as usual. This conversational AI intake system collects medical history information, can be completed by participants at ho...
What is the current status of trial NCT07105397?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2026-04-15. Estimated completion is 2028-06-30.
What interventions are being tested in trial NCT07105397?
The interventions under investigation include: Conversational AI system vs Usual Care (OTHER).
Who is sponsoring clinical trial NCT07105397?
This trial is sponsored by George Mason University, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07105397's enrollment target sits among peer trials
130 733rd of 2000 higher than 1,257 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI